Welcome to UpcomingEvents.com!! We hope to see you at an event SOON!
Search

Select Region

Featured Regions

Philadelphia, PA Baltimore, MD Atlantic City, NJ

Not what you're looking for? See All Cities

Or

Search by Zip

advertise here
  • Home
  • Events
  • Clinical Trials Phase I & IIA Summit

    • This Event has Passed

    Clinical Trials Phase I & IIA Summit

    Thursday, October 17, 2019 - 8:00 AM
    to Friday, October 18, 2019 - 5:00 PM

    8:00 AM - 5:00 PM See all dates and Times

    Sonesta Philadelphia Downtown Rittenhouse Square

    Parking Deals

    http://go.evvnt.com/495324-0?pid=2809

    Add to Calendar

    10/17/2019 08:00 AM 10/18/2019 05:00 PM America/Anguilla Clinical Trials Phase I & IIA Summit Sponsors often take for granted the fact that early phase trial design and operations can make or break future studies. When hard data is severely limited and is used to predict well beyond its boundaries, the quality of that data is absolutely paramount. The data obtained from phase 1 first-in-human studies through phase 2 proof-of-concept and dose range finding studies are vital to effectively designing future registration studies. Early phase clinical trials should be safe experiments on humans, not small-scale phase 3 trials. Therefore, it is beneficial to intelligently optimize early phase clinical activity to ensure successful trial execution and regulatory approval.Prices: Standard: US... Details & Tickets: https://www.upcomingevents.com/philadelphia/events/sonesta-philadelphia-downtown-rittenhouse-square/clinical-trials-phase-i-iia-summit-40778?ref=uceaddevent Sonesta Philadelphia Downtown Rittenhouse Square, 1800 Market Street, Philadelphia, PA, 19103

    Categories

    Health & Wellness

    Sponsors often take for granted the fact that early phase trial design and operations can make or break future studies. When hard data is severely limited and is used to predict well beyond its boundaries, the quality of that data is absolutely paramount. The data obtained from phase 1 first-in-human studies through phase 2 proof-of-concept and dose range finding studies are vital to effectively designing future registration studies. Early phase clinical trials should be safe experiments on humans, not small-scale phase 3 trials. Therefore, it is beneficial to intelligently optimize early phase clinical activity to ensure successful trial execution and regulatory approval.

    Prices:
    Standard: USD 2095.00
    Early Bird: USD 1895.00
    Onsite Pricing: USD 2295.00

    Read More

    View Less

    Top